Detalhe da pesquisa
1.
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.
Gut
; 72(1): 129-140, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197323
2.
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.
Hepatology
; 74(5): 2652-2669, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157147
3.
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
Mol Ther
; 29(2): 680-690, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554867
4.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
J Hepatol
; 73(2): 328-341, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240714
5.
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
J Hepatol
; 66(5): 952-961, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126467
6.
The Complexity of Tobacco Smoke-Induced Mutagenesis in Head and Neck Cancer.
medRxiv
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699364
7.
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Mol Cancer Ther
; 22(4): 485-498, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780225
8.
Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.
Clin Cancer Res
; 28(11): 2449-2460, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302601
9.
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.
Clin Cancer Res
; 28(20): 4509-4520, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998012
10.
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
Clin Cancer Res
; 26(23): 6350-6361, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873569